Speaker illustration

Doctor Matthew Coggins

(United States of America)

Member of:

European Society of Cardiology

Phase I gene therapy clinical trial design of RP-A601 in adult patients with PKP2-arrhythmogenic cardiomyopathy (PKP2-ACM)

Event: ESC Congress 2024

Topic: Trial Design

Session: Cardiovascular trends: hospitalisations, trials, and genetic therapies

Thumbnail